Reviewed,
UniProtKB/Swiss-Prot Q16671 (AMHR2_HUMAN)
Last modified
July 22, 2008.
Version 87.
History...
Clusters with 100%,
90%,
50% identity |
Documents (7) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Anti-Muellerian hormone type-2 receptor EC=2.7.11.30 Alternative name(s): Anti-Muellerian hormone type II receptor Short name(s)=AMH type II receptor MIS type II receptor MISRII Short name(s)=MRII | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 573 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for anti-Muellerian hormone. |
| Catalytic activity | ATP + [receptor-protein] = ADP + [receptor-protein] phosphate. |
| Cofactor | Magnesium or manganese By similarity. |
| Subcellular location | |
| Involvement in disease | Defects in AMHR2 are the cause of persistent Muellerian duct syndrome type 2 (PMDS-2) [MIM:261550]. PMDS-2 is a form of male pseudohermaphroditism characterized by a failure of Muellerian duct regression in otherwise normal males. |
| Sequence similarities | Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily. Contains 1 protein kinase domain. |
Ontologies
Keywords | |
|---|---|
| Cellular component | Membrane |
| Disease | Disease mutation Pseudohermaphroditism |
| Domain | Signal Transmembrane |
| Ligand | ATP-binding Magnesium Manganese Metal-binding Nucleotide-binding |
| Molecular function | Kinase Receptor Serine/threonine-protein kinase Transferase |
| PTM | Glycoprotein |
Gene Ontology (GO) | |
| Biological process | Mullerian duct regression Non-traceable author statement. Source: UniProtKB signal transduction Ref.1Inferred from mutant phenotype. Source: UniProtKB |
| Molecular function | hormone binding Inferred from physical interaction. Source: UniProtKB receptor activity Ref.1Inferred from mutant phenotype. Source: UniProtKB transmembrane receptor protein serine/threonine kinase signaling protein activityTraceable author statement. Source: UniProtKB |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | ||||
Molecule processing | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 17 | 17 | Potential | |||||
| Chain | 18 – 573 | 556 | Anti-Muellerian hormone type-2 receptor | |||||
Regions | ||||||||
| Topological domain | 18 – 149 | 132 | Extracellular Potential | |||||
| Transmembrane | 150 – 170 | 21 | Potential | |||||
| Topological domain | 171 – 573 | 403 | Cytoplasmic Potential | |||||
| Domain | 203 – 518 | 316 | Protein kinase | |||||
| Nucleotide binding | 209 – 217 | 9 | ATP By similarity | |||||
Sites | ||||||||
| Active site | 333 | 1 | Proton acceptor By similarity | |||||
| Binding site | 230 | 1 | ATP By similarity | |||||
Amino acid modifications | ||||||||
| Glycosylation | 66 | 1 | N-linked (GlcNAc...) Potential | |||||
| Glycosylation | 119 | 1 | N-linked (GlcNAc...) Potential | |||||
Natural variations | ||||||||
| Natural variant | 54 | 1 | R → C in PMDS-2. | |||||
| Natural variant | 142 | 1 | G → V in PMDS-2. | |||||
| Natural variant | 282 | 1 | H → Q in PMDS-2. | |||||
| Natural variant | 406 | 1 | R → Q in PMDS-2. | |||||
| Natural variant | 426 | 1 | D → G in PMDS-2. | |||||
| Natural variant | 444 – 452 | 9 | Missing in PMDS-2. | |||||
| Natural variant | 458 | 1 | V → A in PMDS-2. | |||||
| Natural variant | 491 | 1 | D → H in PMDS-2. | |||||
| Natural variant | 504 | 1 | R → C in PMDS-2. | |||||
Experimental info | ||||||||
| Sequence conflict | 161 | 1 | L → V in CAA62593. Ref.2 | |||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Insensitivity to anti-Muellerian hormone due to a mutation in the human anti-Muellerian hormone receptor." Imbeaud S., Faure E., Lamarre I., Mattei M.-G., di Clemente N., Tizard R., Carre-Eusebe D., Belville C., Tragethon L., Tonkin C., Nelson J., McAuliffe M., Bidart J.-M., Lababidi A., Josso N., Cate R.L., Picard J.-Y. Nat. Genet. 11:382-388(1995) [PubMed: 7493017] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | "Structure and chromosomal localization of the human anti-Muellerian hormone type II receptor gene." Visser J.A., McLuskey A., van Beers T., Weghuis D.O., van Kessel A.G., Grootegoed J.A., Themmen A.P.N. Biochem. Biophys. Res. Commun. 215:1029-1036(1995) [PubMed: 7488027] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "Human ovarian cancer, cell lines, and primary ascites cells express the human Muellerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS." Masiakos P.T., MacLaughlin D.T., Maheswaran S., Teixeira J., Fuller A.F. Jr., Shah P.C., Kehas D.J., Kenneally M.K., Dombkowski D.M., Ha T.U., Preffer F.I., Donahoe P.K. Clin. Cancer Res. 5:3488-3499(1999) [PubMed: 10589763] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Testis. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [5] | "A 27 base-pair deletion of the anti-Muellerian type II receptor gene is the most common cause of the persistent Muellerian duct syndrome." Imbeaud S., Belville C., Messika-Zeitoun L., Rey R., di Clemente N., Josso N., Picard J.-Y. Hum. Mol. Genet. 5:1269-1277(1996) [PubMed: 8872466] [Abstract] Cited for: VARIANTS PMDS-2 CYS-54; VAL-142; GLN-282; GLY-426; 444-LEU--GLU-452 DEL; ALA-458; HIS-491 AND CYS-504. |
| [6] | "Autosomal recessive segregation of a truncating mutation of anti-Muellerian type II receptor in a family affected by the persistent Muellerian duct syndrome contrasts with its dominant negative activity in vitro." Messika-Zeitoun L., Gouedard L., Belville C., Dutertre M., Lins L., Imbeaud S., Hughes I.A., Picard J.-Y., Josso N., di Clemente N. J. Clin. Endocrinol. Metab. 86:4390-4397(2001) [PubMed: 11549681] [Abstract] Cited for: VARIANT PMDS-2 GLN-406. |
Cross-references
Sequence databases | |
|---|---|
| X89013 Genomic DNA. Translation: CAA61418.1. U29700 Genomic DNA. Translation: AAC50328.1. X91156 X91166 Genomic DNA. Translation: CAA62593.1. AF172932 mRNA. Translation: AAD48497.1. BC126316 mRNA. Translation: AAI26317.1. | |
| PIR | JC4335. |
| RefSeq | NP_065434.1. |
| UniGene | Hs.659889 |
3D structure databases | |
| HSSP | HSSP built from PDB template 1IAS based on UniProtKB P36897. |
| ModBase | Search... |
Genome annotation databases | |
| Ensembl | ENSG00000135409. Homo sapiens. [Contig view] |
| GeneID | 269. |
| KEGG | hsa:269. |
Organism-specific databases | |
| H-InvDB | HIX0036712. |
| HGNC | HGNC:465. AMHR2. |
| MIM | 261550. phenotype. 600956. gene. |
| Orphanet | 2856. Persistent Mullerian duct syndrome. |
| PharmGKB | PA24770. |
| GenAtlas | Search... |
| GeneCards | Search... |
| GeneLynx | Search... |
Phylogenomic databases | |
| HOGENOM | Q16671. |
| HOVERGEN | Q16671. |
Gene expression databases | |
| ArrayExpress | Q16671. |
| CleanEx | HS_AMHR2. |
| GermOnline | ENSG00000135409. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR017193. Anti-muellerian_hrmn_rcpt_II. IPR015771. Anti-muellerian_hrmn_rcpt_II_C. IPR000719. Prot_kinase_core. IPR017441. Protein_kinase_ATP_bd_CS. IPR017442. Se/Thr_pkinase-rel. IPR008271. Ser_thr_pkin_AS. [Graphical view] |
| PANTHER | PTHR23255:SF4. MIS_II_R. 1 hit. |
| Pfam | PF00069. Pkinase. 1 hit. [Graphical view] |
| PIRSF | PIRSF037392. AMHRII. 1 hit. |
| ProDom | PD000001. Prot_kinase. 1 hit. [Graphical view] [Entries sharing at least one domain] |
| PROSITE | PS00107. PROTEIN_KINASE_ATP. False negative. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. False negative. [Graphical view] |
| BLOCKS | Search... |
Other Resources | |
| DrugBank | DB00171. Adenosine triphosphate. |
| SOURCE | Search... |
| ProtoNet | Search... |
Entry information
| Entry name | AMHR2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q16671 Secondary accession number(s): A0AVE1, Q13762 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| UniProtKB secondary accession numbers Index of UniProtKB secondary accession numbers |
| SIMILARITY comments Index of protein domains and families |

Clusters with


